Clinical Trials
4 trialsNCT06590480 2025-12-18
RPL-EAP-001
Replimune, Inc.
No longer available
NCT03126643 2021-11-29
Expanded Access to Nivolumab (Opdivo)
Bristol-Myers Squibb
Approved for marketing
NCT02475382 2020-11-27
CheckMate 169
Bristol-Myers Squibb
No longer available
NCT02186249 2017-02-08
CheckMate218
Bristol-Myers Squibb
No longer available